原发性硬化性胆管炎(Primary Sclerosing Cholangitis，PSC)是一种慢性胆汁淤积性肝病，其特征是胆管炎症和纤维化导致的胆管狭窄，最终可进展为肝硬化、肝衰竭。

UK MHRA grants marketing approval for Ipsen’s elafibranor to treat adults with rare liver disease known as PCB: United Kingdom Thursday, October 10, 2024, 15:00 Hrs [IST] The Me ...

Ipsen has received the UK Medicines and Healthcare products Regulatory Agency (MHRA) approval for its Elafibranor (Iqirvo) ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved elafibranor (Iqirvo) to treat adult patients with a rare type of liver disease known as primary biliary cholangitis ...

Primary biliary cholangitis (PBC), previously referred to as primary biliary cirrhosis, is a long-term liver condition ...

PBC is a type of chronic liver disease in which the small bile ducts in the liver become injured and inflamed and are ...

Sun Pharma, Torrent Pharma, and other drug companies have refuted claims from the CDSCO report that flagged over 50 medicines ...

Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the European Commission has conditionally approved Iqirvo ® (elafibranor) 80mg tablets for the treatment of primary biliary cholangitis (PBC) in ...

The shares of one of the leading pharma engaged in manufacturing API, Formulation, and Development services rose 3.7% after ...

The European Commission has granted conditional approval for Ipsen's IQIRVO (elafibranor) for the treatment of primary biliary cholangitis in adults, marking the first new therapy for this condition ...